Luke Miels, Executive Vice-President at AstraZeneca, holds ― shares in GlaxoSmithKline (Ticker: GB:GSK), holds ― shares in AstraZeneca (Ticker: GB:AZN).

See the Hottest Stocks Based on Insider Trading >

Luke Miels
AstraZeneca (AZN)
Executive Vice-President

Ranked #65,985 out of 100,370 Corporate Insiders

Profitable Transactions

5 out of 11 Profitable Transactions

Average Return

-5.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Luke Miels does not currently own shares as a corporate insider.

A breakdown of Luke Miels's holdings

See the Top Stocks by Insiders

Insider Roles

AstraZeneca
(AZN)

Executive Vice-President

GlaxoSmithKline
(GSK)

Chief Commercial Officer

Roles that Luke Miels holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

GlaxoSmithKline
(GSK)

Rating:Informative Sell

Date:Feb 20, 2020 - Feb 20, 2021

Return:+22.20%

The most profitable trade made by Luke Miels

See the Latest Stocks Traded by Insiders

Luke Miels's Trading History

AZN

AstraZeneca

May 23, 2016

Executive Vice-President

Uninformative Buy

―

GSK

GlaxoSmithKline

Jan 15, 2025

Chief Commercial Officer

Uninformative Buy

23.37K

―

List of latest transactions for each holding click on a transaction to see Luke Miels's performance on stock

See All Insider Trading from Today

Luke Miels insider profile FAQ

What is the percentage of profitable transactions made by Luke Miels?

The percentage of profitable transactions made by Luke Miels is 45%.

What is the average return per transaction made by Luke Miels?

The average return per transaction made by Luke Miels is -5.90%.

What stocks does Luke Miels hold?

Luke Miels holds: GB:AZN, GB:GSK stocks.

What was Luke Miels’s latest transaction?

Luke Miels latest transaction was an Uninformative Buy of 23.37K.

What was Luke Miels's most profitable transaction?

Luke Miels’s most profitable transaction was an Informative Sell of GB:GSK stock on February 20, 2020. The return on the trade was 22.20%.

What is Luke Miels's role in AstraZeneca?

Luke Miels's role in AstraZeneca is Executive Vice-President.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Luke Miels Insider Profile

Luke Miels AstraZeneca (AZN)Executive Vice-President